A model of molecular interactions on short oligonucleotide microarrays.

Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol (2005) 8.32

Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79

Preprocessing of oligonucleotide array data. Nat Biotechnol (2004) 4.70

Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics (2012) 3.74

Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol (2006) 2.96

Exon arrays provide accurate assessments of gene expression. Genome Biol (2007) 2.86

Simultaneous genotyping, gene-expression measurement, and detection of allele-specific expression with oligonucleotide arrays. Genome Res (2005) 2.66

Issues in the analysis of oligonucleotide tiling microarrays for transcript mapping. Trends Genet (2005) 2.36

Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst (2009) 2.34

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med (2006) 2.26

How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics (2006) 2.13

nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays. Biol Direct (2007) 2.05

Transcript-based redefinition of grouped oligonucleotide probe sets using AceView: high-resolution annotation for microarrays. BMC Bioinformatics (2007) 2.01

Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data. BMC Bioinformatics (2005) 1.96

Sequence dependence of cross-hybridization on short oligo microarrays. Nucleic Acids Res (2005) 1.82

Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol Vis (2003) 1.77

Relationship between gene expression and observed intensities in DNA microarrays--a modeling study. Nucleic Acids Res (2006) 1.74

How replicable are mRNA expression QTL? Mamm Genome (2006) 1.71

Free energy of DNA duplex formation on short oligonucleotide microarrays. Nucleic Acids Res (2006) 1.68

Genomic analysis of adaptive differentiation in Drosophila melanogaster. Genetics (2008) 1.66

Beyond Affymetrix arrays: expanding the set of known hybridization isotherms and observing pre-wash signal intensities. Nucleic Acids Res (2009) 1.54

Tests of rRNA hybridization to microarrays suggest that hybridization characteristics of oligonucleotide probes for species discrimination cannot be predicted. Nucleic Acids Res (2006) 1.46

Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol (2008) 1.45

Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment. PLoS One (2015) 1.42

SFP genotyping from affymetrix arrays is robust but largely detects cis-acting expression regulators. Genetics (2007) 1.38

Detecting transcriptionally active regions using genomic tiling arrays. Genome Biol (2006) 1.37

Brush effects on DNA chips: thermodynamics, kinetics, and design guidelines. Biophys J (2005) 1.37

Preferred analysis methods for Affymetrix GeneChips. II. An expanded, balanced, wholly-defined spike-in dataset. BMC Bioinformatics (2010) 1.34

Specific and nonspecific hybridization of oligonucleotide probes on microarrays. Biophys J (2005) 1.33

Genome-wide identification of direct targets of the Drosophila retinal determination protein Eyeless. Genome Res (2006) 1.32

A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics (2004) 1.28

On-chip non-equilibrium dissociation curves and dissociation rate constants as methods to assess specificity of oligonucleotide probes. Nucleic Acids Res (2006) 1.27

A statistical multiprobe model for analyzing cis and trans genes in genetical genomics experiments with short-oligonucleotide arrays. Genetics (2005) 1.25

Physico-chemical foundations underpinning microarray and next-generation sequencing experiments. Nucleic Acids Res (2013) 1.25

A competitive kinetic model of nucleic acid surface hybridization in the presence of point mutants. Biophys J (2005) 1.24

New perspectives in flooding research: the use of shade avoidance and Arabidopsis thaliana. Ann Bot (2005) 1.23

Quantitative assessment of a novel flow-through porous microarray for the rapid analysis of gene expression profiles. Nucleic Acids Res (2004) 1.22

An improved physico-chemical model of hybridization on high-density oligonucleotide microarrays. Bioinformatics (2008) 1.21

Non-linear analysis of GeneChip arrays. Nucleic Acids Res (2006) 1.21

Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer. Mol Cancer Ther (2010) 1.21

Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes. BMC Genomics (2006) 1.20

Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays. Nucleic Acids Res (2005) 1.20

Transition from positive to neutral in mutation fixation along with continuing rising fitness in thermal adaptive evolution. PLoS Genet (2010) 1.19

The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest (2012) 1.18

Homoeolog-specific transcriptional bias in allopolyploid wheat. BMC Genomics (2010) 1.18

Explaining differences in saturation levels for Affymetrix GeneChip arrays. Nucleic Acids Res (2007) 1.16

Identification of brain transcriptional variation reproduced in peripheral blood: an approach for mapping brain expression traits. Hum Mol Genet (2009) 1.15

Position dependent mismatch discrimination on DNA microarrays - experiments and model. BMC Bioinformatics (2008) 1.15

Experimental optimization of probe length to increase the sequence specificity of high-density oligonucleotide microarrays. BMC Genomics (2007) 1.15

Impact of point-mutations on the hybridization affinity of surface-bound DNA/DNA and RNA/DNA oligonucleotide-duplexes: comparison of single base mismatches and base bulges. BMC Biotechnol (2008) 1.13

Overestimation of alternative splicing caused by variable probe characteristics in exon arrays. Nucleic Acids Res (2009) 1.13

PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays. Nucleic Acids Res (2009) 1.13

Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers. Cancer Prev Res (Phila) (2008) 1.13

Correcting for sequence biases in present/absent calls. Genome Biol (2007) 1.12

Mother-Specific Signature in the Maternal Transcriptome Composition of Mature, Unfertilized Zebrafish Eggs. PLoS One (2016) 1.11

Temperature effects on DNA chip experiments from surface plasmon resonance imaging: isotherms and melting curves. Biophys J (2006) 1.10

Adaptable gene-specific dye bias correction for two-channel DNA microarrays. Mol Syst Biol (2009) 1.09

A multivariate prediction model for microarray cross-hybridization. BMC Bioinformatics (2006) 1.07

Estimation and correction of non-specific binding in a large-scale spike-in experiment. Genome Biol (2007) 1.07

Background correction using dinucleotide affinities improves the performance of GCRMA. BMC Bioinformatics (2008) 1.06

A competitive hybridization model predicts probe signal intensity on high density DNA microarrays. Nucleic Acids Res (2008) 1.05

Improving comparability between microarray probe signals by thermodynamic intensity correction. Nucleic Acids Res (2007) 1.05

Multi-stringency wash of partially hybridized 60-mer probes reveals that the stringency along the probe decreases with distance from the microarray surface. Nucleic Acids Res (2008) 1.05

Weighting by heritability for detection of quantitative trait loci with microarray estimates of gene expression. Genome Biol (2005) 1.05

Improving the sensitivity and specificity of gene expression analysis in highly related organisms through the use of electronic masks. Nucleic Acids Res (2004) 1.03

Position of the fluorescent label is a crucial factor determining signal intensity in microarray hybridizations. Nucleic Acids Res (2005) 1.03

"Hook"-calibration of GeneChip-microarrays: theory and algorithm. Algorithms Mol Biol (2008) 1.02

Morphine effects on striatal transcriptome in mice. Genome Biol (2007) 1.02

Microarrays for pathogen detection and analysis. Brief Funct Genomics (2011) 1.01

Strong position-dependent effects of sequence mismatches on signal ratios measured using long oligonucleotide microarrays. BMC Genomics (2008) 1.00

The effects of mismatches on hybridization in DNA microarrays: determination of nearest neighbor parameters. Nucleic Acids Res (2009) 0.97

G-stack modulated probe intensities on expression arrays - sequence corrections and signal calibration. BMC Bioinformatics (2010) 0.97

The rapamycin-regulated gene expression signature determines prognosis for breast cancer. Mol Cancer (2009) 0.97

Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res (2009) 0.96

Specificity of DNA microarray hybridization: characterization, effectors and approaches for data correction. Nucleic Acids Res (2008) 0.96

Stability of double-stranded oligonucleotide DNA with a bulged loop: a microarray study. BMC Biophys (2011) 0.96

Hybridization thermodynamics of NimbleGen microarrays. BMC Bioinformatics (2010) 0.96

Accurately quantifying low-abundant targets amid similar sequences by revealing hidden correlations in oligonucleotide microarray data. Proc Natl Acad Sci U S A (2006) 0.95

Patterns and processes of genome-wide divergence between North American and African Drosophila melanogaster. Genetics (2010) 0.94

DNA microarray and proteomic strategies for understanding alcohol action. Alcohol Clin Exp Res (2006) 0.94

Methods for evaluating gene expression from Affymetrix microarray datasets. BMC Bioinformatics (2008) 0.94

Resolving deconvolution ambiguity in gene alternative splicing. BMC Bioinformatics (2009) 0.94

Inverse Langmuir method for oligonucleotide microarray analysis. BMC Bioinformatics (2009) 0.94

A review of statistical methods for preprocessing oligonucleotide microarrays. Stat Methods Med Res (2009) 0.92

An intuitive graphical visualization technique for the interrogation of transcriptome data. Nucleic Acids Res (2011) 0.92

A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Cancer Prev Res (Phila) (2010) 0.91

Single-feature polymorphism discovery by computing probe affinity shape powers. BMC Genet (2009) 0.91

Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications. Am J Pathol (2010) 0.90

Gene expression profiling in the rhesus macaque: methodology, annotation and data interpretation. Methods (2009) 0.89

Establishing a major cause of discrepancy in the calibration of Affymetrix GeneChips. BMC Bioinformatics (2007) 0.89

Uncovering pathways in DNA oligonucleotide hybridization via transition state analysis. Proc Natl Acad Sci U S A (2009) 0.89

AffyMiner: mining differentially expressed genes and biological knowledge in GeneChip microarray data. BMC Bioinformatics (2006) 0.88

Software note: using probe secondary structure information to enhance Affymetrix GeneChip background estimates. Comput Biol Chem (2007) 0.88

Thermodynamic scaling behavior in genechips. BMC Bioinformatics (2009) 0.87

A model of base-call resolution on broad-spectrum pathogen detection resequencing DNA microarrays. Nucleic Acids Res (2008) 0.86

Optimising the analysis of transcript data using high density oligonucleotide arrays and genomic DNA-based probe selection. BMC Genomics (2007) 0.85

Development and validation of a species-independent functional gene microarray that targets lactic acid bacteria. Appl Environ Microbiol (2009) 0.85

Hybridization modeling of oligonucleotide SNP arrays for accurate DNA copy number estimation. Nucleic Acids Res (2009) 0.85

Real-time DNA microarrays: reality check. Biochem Soc Trans (2009) 0.84

Robust detection and genotyping of single feature polymorphisms from gene expression data. PLoS Comput Biol (2009) 0.84

A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med (2014) 9.19

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell (2011) 6.43

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol (2010) 6.30

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol (2008) 4.39

NFKBIA deletion in glioblastomas. N Engl J Med (2010) 3.96

Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol (2006) 3.76

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol (2013) 3.52

Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn (2013) 3.36

FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res (2006) 3.28

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol (2011) 3.23

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res (2005) 3.10

Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer (2004) 3.05

Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res (2007) 3.05

Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res (2006) 2.70

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev (2011) 2.48

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw (2011) 2.24

Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer (2004) 2.11

Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J Neurosci (2005) 2.05

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro Oncol (2010) 1.99

Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol (2008) 1.94

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res (2006) 1.91

Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg (2010) 1.85

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res (2005) 1.81

Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc Natl Acad Sci U S A (2007) 1.78

VEGF Trap induces antiglioma effect at different stages of disease. Neuro Oncol (2008) 1.77

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro Oncol (2009) 1.69

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol (2013) 1.63

HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res (2009) 1.61

Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn (2012) 1.59

Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res (2005) 1.57

A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes Dev (2013) 1.55

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol (2011) 1.53

Modulation of gene expression by tumor-derived p53 mutants. Cancer Res (2004) 1.52

The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology (Berl) (2005) 1.51

Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51

Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia (2010) 1.51

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol (2011) 1.50

Identifying gene regulatory networks in schizophrenia. Neuroimage (2010) 1.34

A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regions. J Mol Biol (2002) 1.33

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol (2004) 1.33

Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci (2003) 1.33

Characterization of the ethanol-deprivation effect in substrains of C57BL/6 mice. Alcohol (2006) 1.33

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clin Cancer Res (2006) 1.30

Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med Genomics (2011) 1.29

Genetic dissection of acute ethanol responsive gene networks in prefrontal cortex: functional and mechanistic implications. PLoS One (2012) 1.29

Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev (2008) 1.28

Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics (2008) 1.25

Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res (2008) 1.25

Bayesian ensemble methods for survival prediction in gene expression data. Bioinformatics (2010) 1.24

Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res (2010) 1.21

Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet (2004) 1.21

Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.17

Exploratory analysis of the copy number alterations in glioblastoma multiforme. PLoS One (2008) 1.17

Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol (2014) 1.17

FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res (2010) 1.14

Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res (2007) 1.12

Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst (2005) 1.12

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol (2015) 1.11

Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Cancer Res (2010) 1.11

Conversion of myoblasts to physiologically active neuronal phenotype. Genes Dev (2004) 1.11

Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia (2006) 1.10

Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice. PLoS One (2011) 1.08

Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res (2006) 1.08

Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol (2006) 1.08

Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clin Cancer Res (2013) 1.06

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. Neuro Oncol (2014) 1.06

SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. Cancer Res (2013) 1.06

Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma. Clin Cancer Res (2007) 1.06

SScore: an R package for detecting differential gene expression without gene expression summaries. Bioinformatics (2006) 1.04

ERGR: An ethanol-related gene resource. Nucleic Acids Res (2008) 1.04

New strategies in melanoma: molecular testing in advanced disease. Clin Cancer Res (2012) 1.01

The molecular epidemiology of gliomas in adults. Neurosurg Focus (2005) 1.01

Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest (2010) 1.00

Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet (2003) 0.99

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget (2014) 0.98

A transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among mice. PLoS One (2010) 0.98

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. Mod Pathol (2013) 0.98

Systems genetic analysis of the effects of iron deficiency in mouse brain. Neurogenetics (2012) 0.98

Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett (2008) 0.97

αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell (2013) 0.97

Whole brain and brain regional coexpression network interactions associated with predisposition to alcohol consumption. PLoS One (2013) 0.96

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. J Neurooncol (2006) 0.95

Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res (2011) 0.95

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol (2014) 0.95

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro Oncol (2009) 0.94

DNA microarray and proteomic strategies for understanding alcohol action. Alcohol Clin Exp Res (2006) 0.94

CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. Am J Pathol (2003) 0.93

Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress. J Biol Chem (2012) 0.93

Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol (2012) 0.93

Application of the S-score algorithm for analysis of oligonucleotide microarrays. Methods (2003) 0.93

Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92

Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol (2012) 0.92

Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology (2009) 0.92

Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor. Acta Neuropathol (2011) 0.92

A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg (2010) 0.91

Empirical validation of the S-Score algorithm in the analysis of gene expression data. BMC Bioinformatics (2006) 0.90

Using expression genetics to study the neurobiology of ethanol and alcoholism. Int Rev Neurobiol (2010) 0.90

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol (2012) 0.90